Phase III … “What, you haven’t been Paid !”

8th December 2020 AZD1222 AZD1222 was co-invented by the University of Oxford and its spin-out company, Vaccitech. It uses a replication-deficient chimpanzee viral vector based on a weakened version of a common cold virus (adenovirus) that causes infections in chimpanzees and contains the genetic material of the SARS-CoV-2 virus spike protein. After vaccination, the surfaceContinue reading “Phase III … “What, you haven’t been Paid !””